National CooperativeRx constantly monitors the pharmaceutical pipeline. As treatment options change, it’s important to know how those changes could impact your plan and which drugs bring the highest value. Our quarterly NCRx Pipeline Reports highlight some of the newest therapies coming to market and are not intended to imply formulary placement or coverage by CVS Caremark. Aduhelm®

Diabetes Management Diabetes is a complex and progressive medical condition associated with abnormally elevated blood sugar levels. If left untreated or uncontrolled, diabetes may cause numerous complications and damage to the human body’s organs. Not surprisingly, diabetic medications usually rank among the top spend categories for most plan sponsors. Type 1 diabetes (T1D) is an

National CooperativeRx would like to congratulate Pat Shier for becoming the new secretary/treasurer on our Board of Directors! Following his predecessor Joy Matthews’ completion of a six-year term on our Board last month, Pat was elected by the Board to fill the opening of secretary/treasurer. Pat, Alaska Membership Representative at Pacific Health Coalition (PHC), has

Lowering Costs and Improving Participant Experience In the constantly evolving pharmacy benefit management (PBM) industry, pharmacy expenses and participants’ expectations continue to rise. To keep up, plan sponsors are looking for serious innovation from their providers.  At National CooperativeRx, our membership has benefited from our oversight for many years. To continue to meet those growing

In case you missed it, National CooperativeRx produced its second webinar of our new quarterly series this week that featured our Clinical Services Manager Jocelyn Kerl, PharmD., BCPS, educating the audience on biologic drugs and regulatory implications, the current market status of biosimilars and other highlights plan sponsors should know. Helpful Definitions to Know Biologic

At the heart of any joint purchasing arrangement is a strong contract. The optimal balance of maximizing benefits and controlling costs cannot be achieved for a self-funded plan sponsor without a solid contract from a pharmacy benefit manager (PBM). With 2021 being the final year of a three-year contract, National CooperativeRx hired an independent consultant

Another year, another virtual National CooperativeRx Annual Meeting! Although we were disappointed to miss out on seeing our members and partners in person again, we are impressed with our turnout of 250 attendees and pleased to have delivered the same high-quality, informative keynote presentations our audience has always been accustomed to. Mark O’Connell, our Board

Watch from home. This year, we’re again bringing our Annual Meeting to you! No need for parking passes to enjoy the same quality educational sessions and Cooperative news you’ve been accustomed to in the past from us. John Barlament, Partner at Quarles & Brady LLP, will provide knowledge on how the new administration’s policies and strategies

National CooperativeRx constantly monitors the pharmaceutical pipeline. As treatment options change, it’s important to know how those changes could impact your plan and which drugs bring the highest value. Our quarterly NCRx Pipeline Reports highlight some of the newest therapies coming to market and are not intended to imply formulary placement or coverage by CVS Caremark. Varenicline

The Cooperative’s new Advanced Utilization Management (UM) Program has officially launched! National CooperativeRx constantly monitors the pharmaceutical marketplace for new therapies in the pipeline. We have implemented our opt-in Advanced UM program to offer our member groups an opportunity to employ our recommendations on a quarterly basis to better adapt their plans to the rapidly